Search

everythinglearnresearchcommunity

for

Search:↓

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Alopecia patients have less GPER-1, which might affect hair loss.

New treatments for male hypogonadism are effective and should be personalized.

Using neurohormones to control keratin can lead to new skin disease treatments.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Finding functions for unknown GPCRs is hard but key for making new drugs.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Androgens and other hormones affect hair growth and skin conditions like acne.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.